Literature DB >> 33124883

NO-induced vasodilation correlates directly with BP in smooth muscle-Na/Ca exchanger-1-engineered mice: elevated BP does not attenuate endothelial function.

Youhua Wang1,2, Jin Zhang1, W Gil Wier1, Ling Chen1,3, Mordecai P Blaustein1,3.   

Abstract

Arterial smooth muscle Na+/Ca2+ exchanger-1 (SM-NCX1) promotes vasoconstriction or vasodilation by mediating, respectively, Ca2+ influx or efflux. In vivo, SM-NCX1 mediates net Ca2+ influx to help maintain myogenic tone (MT) and neuronally activated constriction. SM-NCX1-TG (overexpressing transgenic) mice have increased MT and mean blood pressure (MBP; +13.5 mmHg); SM-NCX1-KO (knockout) mice have reduced MT and MBP (-11.1 mmHg). Endothelium-dependent vasodilation (EDV) is often impaired in hypertension. We tested whether genetically engineered SM-NCX1 expression and consequent BP changes similarly alter EDV. Isolated, pressurized mesenteric resistance arteries with MT from SM-NCX1-TG and conditional SM-NCX1-KO mice, and femoral arteries in vivo from TG mice were studied. Acetylcholine (ACh)-dilated TG arteries with MT slightly more than control or KO arteries, implying that SM-NCX1 overexpression does not impair EDV. In preconstricted KO, but not TG mouse arteries, however, ACh- and bradykinin-triggered vasodilation was markedly attenuated. To circumvent the endothelium, phenylephrine-constricted resistance arteries were tested with Na-nitroprusside [SNP; nitric oxide (NO) donor] and cGMP. This endothelium-independent vasodilation was augmented in TG but attenuated in KO arteries that lack NCX1-mediated Ca2+ clearance. Baseline cytosolic Ca2+ ([Ca2+]cyt) was elevated in TG femoral arteries in vivo, supporting the high BP; furthermore, SNP-triggered [Ca2+]cyt decline and vasodilation were augmented as NO and cGMP promote myocyte polarization thereby enhancing NCX1-mediated Ca2+ efflux. The TG mouse data indicate that BP elevation does not attenuate endothelium-dependent vasodilation. Thus, in essential hypertension and many models the endothelial impairment that supports the hypertension apparently is not triggered by BP elevation but by extravascular mechanisms.NEW & NOTEWORTHY Endothelium-dependent, ACh-induced vasodilation (EDV) is attenuated, and arterial myocyte Na+/Ca2+ exchangers (NCX1) are upregulated in many forms of hypertension. Surprisingly, mildly hypertensive smooth muscle-specific (SM)-NCX1 transgenic mice exhibited modestly enhanced EDV and augmented endothelium-independent vasodilation (EIV). Conversely, mildly hypotensive SM-NCX1-knockout mice had greatly attenuated EIV. These adaptations help compensate for NCX1 expression-induced alterations in cytosolic Ca2+ and blood pressure (BP) and belie the view that elevated BP, itself, causes the endothelial dysregulation in hypertension.

Entities:  

Keywords:  acetylcholine; mesenteric artery; myogenic tone; sodium nitroprusside; vasodilation

Mesh:

Substances:

Year:  2020        PMID: 33124883      PMCID: PMC7847073          DOI: 10.1152/ajpheart.00487.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  118 in total

1.  Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries.

Authors:  B K Kemp; T M Cocks
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

2.  Mechanism of coronary vasodilation produced by bradykinin.

Authors:  L R Pelc; G J Gross; D C Warltier
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

3.  Role of K+ channels and sodium pump in the vasodilation induced by acetylcholine, nitric oxide, and cyclic GMP in the rabbit aorta.

Authors:  M Ferrer; J Marín; A Encabo; M J Alonso; G Balfagón
Journal:  Gen Pharmacol       Date:  1999-07

Review 4.  Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation.

Authors:  John W Osborn; Gregory D Fink; Marcos T Kuroki
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

5.  Mechanisms of U46619-induced contraction in mouse intrarenal artery.

Authors:  Hong Yan; Meng-Zhen Zhang; Gordon Wong; Lin Liu; Yat Sze Shelia Kwok; Su-Juan Kuang; Hui Yang; Fang Rao; Xin Li; Li-Ping Mai; Qiu-Xiong Lin; Min Yang; Qian-Huan Zhang; Chun-Yu Deng
Journal:  Clin Exp Pharmacol Physiol       Date:  2019-04-17       Impact factor: 2.557

6.  Coronary vasodilation to acetylcholine, adenosine and bradykinin in dogs: effects of inhibition of NO-synthesis and captopril.

Authors:  J Zanzinger; E Bassenge
Journal:  Eur Heart J       Date:  1993-11       Impact factor: 29.983

7.  Dominant negative PPARγ promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscle.

Authors:  Christopher J Pelham; Henry L Keen; Steven R Lentz; Curt D Sigmund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-27       Impact factor: 3.619

8.  cAMP modulates cGMP-mediated cerebral arteriolar relaxation in vivo.

Authors:  Hao-Liang Xu; Hailemariam M Wolde; Vitaliy Gavrilyuk; Verna L Baughman; Dale A Pelligrino
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-22       Impact factor: 4.733

9.  cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells.

Authors:  B E Robertson; R Schubert; J Hescheler; M T Nelson
Journal:  Am J Physiol       Date:  1993-07

Review 10.  Endothelial dysfunction and vascular disease - a 30th anniversary update.

Authors:  P M Vanhoutte; H Shimokawa; M Feletou; E H C Tang
Journal:  Acta Physiol (Oxf)       Date:  2016-01-25       Impact factor: 6.311

View more
  2 in total

Review 1.  The Contribution of Gut Microbiota and Endothelial Dysfunction in the Development of Arterial Hypertension in Animal Models and in Humans.

Authors:  Jessica Maiuolo; Cristina Carresi; Micaela Gliozzi; Rocco Mollace; Federica Scarano; Miriam Scicchitano; Roberta Macrì; Saverio Nucera; Francesca Bosco; Francesca Oppedisano; Stefano Ruga; Anna Rita Coppoletta; Lorenza Guarnieri; Antonio Cardamone; Irene Bava; Vincenzo Musolino; Sara Paone; Ernesto Palma; Vincenzo Mollace
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

2.  Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt-Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling.

Authors:  Yu Zhao; Li Li; Zongshi Lu; Yingru Hu; Hexuan Zhang; Fang Sun; Qiang Li; Chengkang He; Wentao Shu; Lijuan Wang; Tingbing Cao; Zhidan Luo; Zhencheng Yan; Daoyan Liu; Peng Gao; Zhiming Zhu
Journal:  J Am Heart Assoc       Date:  2022-07-29       Impact factor: 6.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.